Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Dong Wha reports novel agents for hepatitis B and C infection

Feb. 19, 2003

Altus and Dr. Falk form alliance to develop TheraCLEC in Europe

Feb. 14, 2003

Novel 5-HT4 ligands and their use in gastrointestinal disorders

Feb. 14, 2003

Inhibitors of HCV NS5B polymerase identified at GSK

Feb. 7, 2003

IND cleared for NCX-1000

Feb. 6, 2003

Novel agents for gastroesophageal reflux disease identified at AstraZeneca

Feb. 3, 2003

Calcium antagonists and their use in IBS reported by Ajinomoto

Jan. 30, 2003

Shire BioChem scientists report new agents for hepatitis C virus

Jan. 30, 2003

Inhibitors of HCV RNA replication discovered at Roche

Jan. 29, 2003

FR-167653 as a potential new therapy for endotoxemia

Jan. 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...